Loading...
Chemical structure of ACT-777991

GC71073

ACT-777991

Also known as 1-[(2R)-2-(2-hydroxyethyl)-4-[2-(trifluoromethyl)-4-[2-(trifluoromethyl)pyrimidin-5-yl]-1,3-thiazol-5-yl]piperazin-1-yl]-2-(3-methyl-1,2,4-triazol-1-yl)ethanone

ACT-777991 is an orally active and selective CXCR3 antagonist

ChemicalCAS1967811-46-6MW550.48FormulaC20H20F6N8O2S
CAS number
1967811-46-6
Molecular weight
550.48
Formula
C20H20F6N8O2S
Solubility
DMSO ： 100 mg/mL (181·66 mM; Need ultrasonic; Hygroscopic DMSO has a significant impact on the solubility of product, please use newly opened DMSO)
InChIKey
FDZFVXKCJKOSRC-CYBMUJFWSA-N
Catalogue number
GC71073
Brand
GLPBIO
Computed properties PubChem CID 121485701 · XLogP 2.5 · TPSA 141 Ų · H-bond donors 1
XLogP
2.5
TPSA
141 Ų
H-bond donors
1
H-bond acceptors
15
Rotatable bonds
6
Heavy atoms
37

SMILES CC1=NN(C=N1)CC(=O)N2CCN(C[C@H]2CCO)C3=C(N=C(S3)C(F)(F)F)C4=CN=C(N=C4)C(F)(F)F

Computed descriptors from PubChem (CID 121485701), public domain. Identity cross-checked against the supplier's molecular formula and weight — verify before use.

Ordering in Israel

Lead time
Ships from the manufacturer to your lab in 8–14 business days; customs and cold chain handled by LABO Scientific.
Pricing
Quoted in ILS, excl. VAT. Add the item to your quote and we confirm the final price, usually the same business day.
Documents
Lot certificate of analysis and manufacturer SDS are emailed with your order confirmation.
Who we serve
Universities, hospitals and biotech companies across Israel. Research use only — not for diagnostic or therapeutic use.